Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
BMC Pregnancy and Childbirth
Erschienen in: BMC Pregnancy and Childbirth 1/2023

Open Access 01.12.2023 | Research

Differential immunophenotype of circulating monocytes from pregnant women in response to viral ligands

verfasst von: Marcelo Farias-Jofre, Roberto Romero, Yi Xu, Dustyn Levenson, Li Tao, Tomi Kanninen, Jose Galaz, Marcia Arenas-Hernandez, Zhenjie Liu, Derek Miller, Gaurav Bhatti, Megan Seyerle, Adi L. Tarca, Nardhy Gomez-Lopez

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2023

insite
INHALT
download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Viral infections during pregnancy can have deleterious effects on mothers and their offspring. Monocytes participate in the maternal host defense against invading viruses; however, whether pregnancy alters monocyte responses is still under investigation. Herein, we undertook a comprehensive in vitro study of peripheral monocytes to characterize the differences in phenotype and interferon release driven by viral ligands between pregnant and non-pregnant women.

Methods

Peripheral blood was collected from third-trimester pregnant (n = 20) or non-pregnant (n = 20, controls) women. Peripheral blood mononuclear cells were isolated and exposed to R848 (TLR7/TLR8 agonist), Gardiquimod (TLR7 agonist), Poly(I:C) (HMW) VacciGrade™ (TLR3 agonist), Poly(I:C) (HMW) LyoVec™ (RIG-I/MDA-5 agonist), or ODN2216 (TLR9 agonist) for 24 h. Cells and supernatants were collected for monocyte phenotyping and immunoassays to detect specific interferons, respectively.

Results

The proportions of classical (CD14hiCD16−), intermediate (CD14hiCD16+), non-classical (CD14loCD16+), and CD14loCD16− monocytes were differentially affected between pregnant and non-pregnant women in response to TLR3 stimulation. The proportions of pregnancy-derived monocytes expressing adhesion molecules (Basigin and PSGL-1) or the chemokine receptors CCR5 and CCR2 were diminished in response to TLR7/TLR8 stimulation, while the proportions of CCR5− monocytes were increased. Such differences were found to be primarily driven by TLR8 signaling, rather than TLR7. Moreover, the proportions of monocytes expressing the chemokine receptor CXCR1 were increased during pregnancy in response to poly(I:C) stimulation through TLR3, but not RIG-I/MDA-5. By contrast, pregnancy-specific changes in the monocyte response to TLR9 stimulation were not observed. Notably, the soluble interferon response to viral stimulation by mononuclear cells was not diminished in pregnancy.

Conclusions

Our data provide insight into the differential responsiveness of pregnancy-derived monocytes to ssRNA and dsRNA, mainly driven by TLR8 and membrane-bound TLR3, which may help to explain the increased susceptibility of pregnant women to adverse outcomes resulting from viral infection as observed during recent and historic pandemics.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12884-023-05562-0.
The study was conducted at the Perinatology Research Branch, NICHD/NIH/DHHS, in Detroit, Michigan; the Branch has since been renamed as the Pregnancy Research Branch, NICHD/NIH/DHHS.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CCL
C–C motif chemokine ligand
CCR
C–C motif chemokine receptor
cffDNA
Cell-free fetal DNA
CXCL
C-X-C motif chemokine ligand
CXCR
C-X-C motif chemokine receptor
dsRNA
Double-stranded RNA
HMW
High molecular weight
IFN
Interferon
MDA5
Melanoma differentiation-associated protein 5
mtDNA
Mitochondrial DNA
PBMC
Peripheral blood mononuclear cell
PSGL-1
P-selectin glycoprotein ligand-1
RIG-I
Retinoic acid-inducible gene I
ssRNA
Single-stranded RNA
TLR
Toll-like receptor

Background

Infection during pregnancy is one of the leading causes of maternal mortality and morbidity worldwide, accounting for more than 10% of all deaths [1]. Notably, both viral and bacterial infections have been linked to adverse pregnancy outcomes [2]. Indeed, viral infection during pregnancy has been associated with increased risk of pregnancy complications such as miscarriage, stillbirth, preterm birth, pre-eclampsia, fetal growth restriction, and congenital defects, among others [3‐6]. Considering past and recent viral pandemics, as well as the growing knowledge of viral infection during pregnancy, it has become evident that specific viral infections can have devastating short- and long-term effects on both the mother and offspring [7‐17]. Thus, it is imperative to elucidate the underlying mechanisms whereby viral infection disproportionately impacts pregnant women to design novel preventative and therapeutic approaches.
Viruses are broadly classified by the type of carried genetic material (RNA or DNA) and display infection strategies that vary accordingly [18]. Moreover, each type of virus, together with its mechanisms of replication, requires tailored mechanisms of detection and clearance by host cells [19‐22]. Importantly, although viral proteins typically elicit an intense initial immune response, the higher viral mutation rates make continuous surveillance by the host immune system challenging [23, 24]. Thus, the ability to detect general patterns of viral genetic material is a critical component of the early antiviral immune response that is primarily accomplished by innate immune cells such as monocytes [21, 25‐27].
Monocytes are part of the first line of defense against pathogens, including viral infection [28‐32]. These innate immune cells are equipped to detect and kill microbes, being the primary subset of circulating mononuclear phagocytic cells, and are capable of quickly secreting pro-inflammatory cytokines in response to viral encounter [33‐35]. Monocytes express multiple pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), which can recognize conserved viral motifs known as pattern-associated molecular patterns (PAMPs) [27, 36]. Intracellular PRRs include TLR3, TLR7, TLR8, and TLR9, all of which are located within the endosomal membrane [37‐40] and are specific for double-stranded (ds)RNA (TLR3) [41], single-stranded (ss)RNA (TLR7, TLR8) [42, 43], or dsDNA (TLR9) [44‐46]. Cells also express specific PRRs within the cytosolic space, such as Retinoic Acid-Inducible Gene I (RIG-I) and Melanoma Differentiation-Associated Protein 5 (MDA5) [47], both of which detect dsRNA [48]. Interestingly, some viruses can be recognized by multiple PRRs due to their replication cycle, which includes phases wherein the virus contains both dsRNA and ssRNA [47, 49‐52]. Thus, the host response to viruses is complex and requires the expression of multiple PRRs by sentinel cells such as monocytes. Given that monocytes are increased in number [53‐56] and display activated phenotypes during pregnancy [56‐60], such innate immune cells are likely primed to participate in maternal response to viral infection. However, the evaluation of circulating monocyte responses to different types of virus during pregnancy has not been undertaken.
Herein, we performed a comprehensive in vitro study of peripheral monocyte responses to viral genetic material mimetics in pregnant and non-pregnant women. We investigated the population distribution and expression of surface proteins (i.e., adhesion molecules and chemokine receptors) by conventional monocyte subsets (classical, intermediate, non-classical, and CD14loCD16−) using flow cytometry. In addition, we profiled specific type I, II, and III interferons released by monocytes in response to viral ligand stimulation. Together, these data provide an overview of changes in the monocyte response to viral infection during pregnancy.

Methods

Human subjects, clinical specimens, and definitions

Peripheral blood samples were obtained from August 2020 – February 2021 from healthy pregnant and non-pregnant women recruited by the Pregnancy Research Branch, an intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), U.S. Department of Health and Human Services, Wayne State University (Detroit, MI, USA), and the Detroit Medical Center (Detroit, MI, USA). Blood sample collection was performed from all women after obtaining written informed consent. The collection and use of biological specimens for research purposes was approved by the respective Institutional Review Boards of Wayne State University and the Detroit Medical Center (WSU IRB 031318MP2F). The present study included pregnant women (n = 20), predominantly African American, whose peripheral blood was collected in the third trimester at a median gestational age of 39.1 (ranging from 37.4 – 41) weeks prior to the onset of labor or administration of any medication. The control study group comprised healthy non-pregnant women (n = 20) of reproductive age from the same community, of whom all except one had never been pregnant.

Stimulation of peripheral blood mononuclear cells with viral ligands

Peripheral blood samples were obtained by venipuncture and collected into EDTA tubes. Peripheral blood mononuclear cells (PBMCs) were isolated using the Lymphoprep density gradient medium (Cat# 07801; StemCell Technologies Inc., Vancouver, Canada), per the manufacturer’s instructions. Isolated PBMCs were cultivated in RPMI 1640 Medium (Cat# 11875–093; Thermo Fisher Scientific, Life Technologies Limited, Paisley, UK) supplemented with 5% human serum (Cat# H3667; Sigma-Aldrich, St Louis, MO, USA) and 1% Penicillin–Streptomycin (Cat# 15140122; Thermo Fisher Scientific). The cells were plated onto cell culture plates at a density of 1 × 106 cells/mL prior to treatment. For viral ligand stimulation, PBMCs were individually incubated with 2.5 µg/mL R848 (TLR7/8-based adjuvant; Cat# vac-r848; InvivoGen, San Diego, CA, USA), 1 µM Gardiquimod (TLR7 ligand; Cat# tlrl-gdqs; InvivoGen), 10 µg/mL Poly(I:C) (HMW) VacciGrade™ (TLR3-based adjuvant; Cat# vac-pic; InvivoGen), 50 µg/mL Poly(I:C) (HMW) LyoVec™ (RIG-I/MDA-5 ligand; Cat# tlrl-piclv; InvivoGen), and 2 µg/mL ODN 2216 (TLR9 ligand; Cat# tlrl-2216; InvivoGen) at 37 °C with 5% CO2 for 24 h with the addition of protein transport inhibitor cocktail (Cat# 00-4980-03; ThermoFisher Scientific) for the last 4 h of incubation. Following incubation, the isolated PBMCs were gently collected using a cell scraper and centrifuged at 300 × g and 4 °C for 5 min. Finally, the resulting cell supernatants from PBMCs were stored at -80 °C prior to cytokine profiling, while the cell pellets were immediately processed for immunophenotyping.

Immunophenotyping

Collected PBMC pellets were resuspended in 1X phosphate-buffered saline (PBS; Life Technologies Limited, Pailey, UK) and incubated with 1 µL/mL of Fixable Viability Stain 510 (Cat# 564406; BD Biosciences, Franklin Lakes, NJ, USA) in the dark at room temperature for 15 min. Next, cells were washed and resuspended in FACS Stain Buffer (Cat# 554656; BD Biosciences). Extracellular anti-human monoclonal antibodies (Supplementary Table 1) were added to the cell suspensions, which were incubated in the dark at 4 °C for 30 min. Cells were then fixed and permeabilized using the BD Cytofix/Cytoperm Kit (Cat# 554714; BD Biosciences), according to the manufacturer’s instructions. Following permeabilization, intracellular anti-human monoclonal antibodies (Supplementary Table 1) were added to cell suspensions, which were incubated in the dark at 4 °C for 30 min. Finally, the cells were washed and resuspended in 0.5 mL of FACS Stain Buffer and acquired using the BD LSR Fortessa flow cytometer (BD Biosciences) with FACSDiva 9.0 software (BD Biosciences). FlowJo software version 10 (TreeStar, Ashland, OR, USA) was used to perform data analysis and create figures. Monocytes were identified as CD14+ cells. As shown in Supplementary Fig. 1, monocyte subsets were classified as follows: classical monocytes (CD14hiCD16−), intermediate monocytes (CD14hiCD16+), non-classical monocytes (CD14loCD16+), and CD14loCD16− monocytes. Additional markers (Supplementary Table 1) were used to further immunophenotype cells within the identified subsets.

Interferon profile of viral ligand-stimulated PBMCs

PBMCs were isolated, cultured, and the resulting cell supernatants were collected as previously described. The concentrations of interferons were determined in cell supernatants using the U-PLEX Interferon Combo (human) (Cat# K15094K-1; Meso Scale Discovery, Rockville, MD, USA), following the manufacturer’s instructions. The following immune mediators were assayed: IFN-α2a, IFN-β, IFN-γ, and IL-29/IFN-λ1. A MESO QuickPlex SQ 120 was used to read the plates, and cytokine concentrations were calculated using the Discovery Workbench software version 4.0 (Meso Scale Discovery). The assay sensitivities were: 4 pg/mL (IFN-α2a), 3.1 pg/mL (IFN-β), 1.7 pg/mL (IFN-γ), and 1.2 pg/mL (IL-29/IFN-λ1).

Statistical analyses

The R statistical programming language was used to perform all statistical analyses. Linear mixed effects models were fit for the comparison of flow cytometry data and cytokine concentrations between groups to account for repeated measurements. The data obtained by flow cytometry were modeled as frequencies. A false discovery rate adjusted p-value (q-value) < 0.05 was considered statistically significant. Differences in proportions of monocytes subsets are represented as heatmaps, and selected significant comparisons are displayed as box and whiskers plots. GraphPad Prism version 9.5.1 for Windows (GraphPad Software, San Diego, California, USA, www.​graphpad.​com) was used to conduct statistical analysis to evaluate differences in interferon concentrations using the Kruskal–Wallis test with post hoc multiple comparisons. A p-value < 0.05 was considered statistically significant.

Results

TLR8 drives the response to ssRNA stimulation in pregnancy-derived monocytes

Infection with single-stranded RNA (ssRNA) viruses such as rubella, enterovirus, measles, mumps, ebola, HIV, influenza, and coronaviruses has been linked to increased risk of adverse pregnancy outcomes [8, 61‐65]. Since ssRNA genetic material can be sensed by TLR7 and TLR8, we first aimed to investigate whether stimulation with synthetic ligands for these receptors elicits a differential response during pregnancy. PBMCs were isolated from pregnant and non-pregnant women and stimulated with R848, an agonist of both TLR7 and TLR8 (Fig. 1A). Total monocytes (CD14+ cells) as well as classical (CD14hiCD16−), intermediate (CD14hiCD16+), non-classical (CD14loCD16+), and CD14loCD16− monocytes were evaluated by flow cytometry (Fig. 1B). The proportions of each monocyte subset displayed similar shifts upon R848 stimulation for both pregnant and non-pregnant women (Fig. 1C). Differential responses after R848 stimulation were observed for pregnant- and non-pregnant-derived circulating monocytes, as shown in the heatmap representation in Fig. 1D. Specifically, exposure to R848 induced a significant change in the same direction and of similar magnitude in both pregnant- and non-pregnant-derived classical (Fig. 1E), intermediate (Fig. 1F), non-classical (Fig. 1G) and CD14loCD16− monocytes (Fig. 1H). By contrast, R848-stimulated monocytes from pregnant women showed reduced proportions of CD147+ (Fig. 1I), CD162+ (Fig. 1J), and CCR5+CCR2+ (Fig. 1K) cells as well as increased proportions of CCR5−CCR2+ (Fig. 1L) and CCR5−CCR2− (Fig. 1M) cells compared with those from non-pregnant women, suggesting subtle pregnancy-driven differences in the monocyte response. No differences were found between pregnant- and non-pregnant-derived CCR5+CCR2− monocytes (Fig. 1N) upon R848 stimulation. Taken together, these findings demonstrate that monocytes from pregnant and non-pregnant women respond to TLR7 and TLR8 stimulation. Yet, pregnancy is associated with reduced proportions of cells expressing adhesion molecules such as CD147 and CD162, as well as diminished proportions of cells expressing both CCR2 and CCR5 in response to TLR7/TLR8 stimulation.
We next used the specific TLR7 agonist Gardiquimod to distinguish responses specific to this PRR from those driven by either TLR7 or TLR8 (Fig. 1A). We found that TLR7-specific stimulation resulted in distinct effects on pregnant and non-pregnant-derived monocyte subsets (Fig. 2A). Overall, TLR7 stimulation induced more specific alterations of monocyte subpopulations (Fig. 2B) compared to the broad effects of R848 (Fig. 1D). Although the exposure to TLR7 stimulation differentially affected the proportions of pregnant and non-pregnant-derived classical (Fig. 2C), intermediate (Fig. 2D), and non-classical (Fig. 2E) monocytes, no pregnancy-specific differences were found between stimulated monocytes. Moreover, CD14loCD16− monocytes derived from both pregnant and non-pregnant women showed no change in proportion in response to TLR7 stimulation (Fig. 2F). Of note, the proportions of TLR7 stimulated monocytes expressing specific adhesion molecules or chemokine receptors did not differ between pregnant and non-pregnant women. Taken together, these results suggest that the differential responses observed in monocytes from pregnant women upon exposure to the TLR7/8 agonist are primarily driven by TLR8 stimulation.

Pregnancy modulates the monocyte response to dsRNA

Double-stranded RNA (dsRNA) viruses, such as rotavirus, are known to cause gastroenteritis in non-pregnant individuals [66, 67]. However, the maternal immune response to this viral infection and the subsequent transfer of protective antibodies to the offspring play a key role in the prevention of severe neonatal disease, particularly in premature neonates [68]. Therefore, we next evaluated the response of circulating monocytes to dsRNA-based viral ligands. dsRNA structures are sensed by the endosomal TLR3 or cytosolic RIG-I/MDA5 receptors, depending on the intracellular site of detection. Specific stimulation of endosomal or cytosolic receptors can be achieved separately using only dsRNA structures (such as poly(I:C)) or dsRNA structures combined with a transfecting reagent (Poly(I:C) (HMW) LyoVec™), respectively. Thus, PBMCs isolated from the peripheral blood of pregnant and non-pregnant women were stimulated with poly(I:C) (HMW) Vaccigrade™ (TLR3 agonist) or poly(I:C) (HMW) LyoVec™ (RIG-I/MDA5 agonist) (Fig. 3A). The proportions of primary monocyte subsets (Fig. 3B) were skewed upon TLR3 stimulation in both study groups, with classical and intermediate monocyte subsets being enhanced or diminished, respectively (Fig. 3C). Moreover, the proportions of CD142+, CXCL10+, IL-6+, CCR5+CCR2−, CCR5+CCR2+, and CD182−CD181+ monocytes were increased in both groups in response to stimulation, while the CX3CR1+, CCR5−CCR2+, and CD182−CD181− monocyte subsets were reduced (Fig. 3C). Interestingly, we observed reduced proportions of classical (Fig. 3D) and CD14loCD16− monocytes (Fig. 3E), as well as an increased proportion of intermediate monocytes (Fig. 3F) in pregnant women compared to non-pregnant women upon TLR3 stimulation. No changes in the proportion of non-classical monocytes were observed (Fig. 3G). While the proportions of monocytes expressing CD147 (Fig. 3H) or CD162 (Fig. 3I) were not modified by TLR3 stimulation, pregnancy was associated with differential changes in the proportions of monocytes expressing the IL-8 receptors CD181 and CD182 [69, 70] as well as monocytes lacking these markers (Figs. 3J-M). Specifically, the proportion of pregnancy-derived monocytes expressing CD181 alone (Fig. 3J) or in combination with CD182 (Fig. 3K) was increased in response to TLR3 stimulation compared to cells isolated from non-pregnant women.
Similar to the results of TLR3 stimulation, the proportions of primary monocyte subsets showed elevated proportions of classical, non-classical, and CD14loCD16− monocytes together with reduced intermediate monocytes after exposure to RIG-I/MDA5 stimulation (Fig. 4A). Moreover, this cytosolic dsRNA agonist induced an extensive phenotypic response in monocytes from both pregnant and non-pregnant women (Fig. 4B); yet, pregnancy was not associated with differential effects for the majority of evaluated subsets. Indeed, the proportions of classical (Fig. 4C), intermediate (Fig. 4D), and non-classical (Fig. 4E) monocytes showed comparable responses between pregnant and non-pregnant samples stimulated with the RIG-I/MDA5 agonist. Only the proportion of CD14loCD16− monocytes subset differed between pregnant and non-pregnant women, with CD14loCD16− monocytes from non-pregnant women showing increased proportions in response to stimulation (Fig. 4F). Taken together, these findings suggest that pregnancy does not greatly modify the monocyte response to intracellular dsRNA; yet, the recognition of this dsRNA by endosomal TLR3 induces a distinct phenotype in monocytes from pregnant women.

Pregnancy does not modify the monocyte response to dsDNA

Among double-stranded DNA (dsDNA) viruses, adenovirus, CMV, and herpesvirus infections have each been associated to increased risk for pregnancy complications such as fetal death or preterm birth, among others [3, 71, 72]. Therefore, we last evaluated the circulating monocyte response to dsDNA structures using the synthetic TLR9 agonist ODN2216 (Fig. 5A). Notably, the proportions of the primary monocyte subsets were largely unaltered upon stimulation with the TLR9 agonist, regardless of pregnancy status (Fig. 5B). Nonetheless, TLR9 stimulation enhanced the proportions of monocytes with a CCR5+CCR2+ phenotype while diminishing the CCR5−CCR2+ subset in both study groups (Fig. 5C). Other monocyte phenotypes also tended to be elevated in response to TLR9 stimulation, including CD142+, CX3CR1+, CXCL10+, IL-6+, and CCR5+CCR2− cells; however, no pregnancy-specific differences were observed (Fig. 5C-G). These results are indicative of a consistent response towards dsDNA in circulating monocytes that is independent of pregnancy status.

Pregnancy does not impair the release of interferons by mononuclear cells in response to RNA viral ligands

Up to this point, our results indicate that pregnancy is associated with differential circulating monocyte responses upon exposure to RNA-based, but not DNA-based, viral ligands. Therefore, we last aimed to investigate whether the release of soluble immune mediators by mononuclear cells in response to RNA-based viral ligands differs between pregnant and non-pregnant women. As interferons (IFNs) are the primary early antiviral mediators secreted by immune and non-immune cells [73‐76], we next measured the concentrations of IFN-α2a and IFN-β (type I IFNs), IFN-γ (type II IFN), and IL-29/IFN-λ1 (type III IFN) released upon in vitro stimulation of PBMCs with TLR7/8 or TLR3 agonists (Fig. 6A). The baseline production of IFNs was negligible by PBMCs from pregnant and non-pregnant women (Fig. 6B-I). Stimulation with a TLR7/TLR8 agonist (R848) resulted in elevated concentrations of IFN-α2a (Fig. 6B), IFN-β (Fig. 6C), IFN-γ (Fig. 6D), and IL-29/IFN-λ1 (Fig. 6E) released by PBMCs from pregnant and non-pregnant women. Consistently, concentrations of IFN-α2a (Fig. 6F), IFN-γ (Fig. 6H), and IL-29/IFN-λ1 (Fig. 6I) were increased in response to TLR3 stimulation (via poly(I:C) (HMW) Vaccigrade™). Notably, the latter stimulus resulted in elevated release of IFN-β by PBMCs from pregnant women, but not from non-pregnant women (Fig. 6G). Thus, our results suggest that circulating mononuclear cells from pregnant women retain the capacity to effectively release IFNs in response to viral stimulation.

Discussion

Herein, we showed that the frequency of monocytes expressing the adhesion molecules CD147 and CD162 was diminished in pregnant women in response to TLR7/TLR8 stimulation. CD147, commonly termed Basigin, is a membrane receptor and member of the immunoglobulin superfamily that participates in cellular functions including migration and adhesion [77‐80]. Similarly, CD162, or P-selectin glycoprotein ligand-1 (PSGL-1), acts as a ligand for selectins and is also a key player in leukocyte migration/adhesion [81‐83]. Cellular adhesion molecules are among the primary points of cell entry for multiple viral families [84], and the modulation of such receptors can be a mechanism for viral pathogenicity. For example, the ssRNA Zika virus was shown to upregulate integrins and other adhesion molecules in monocytes, which potentially enhanced dissemination into neural cells [85]. Importantly, infection with ssRNA viruses during pregnancy is linked to increased risk of adverse outcomes and more severe clinical features compared to non-pregnant patients [8, 61, 63‐65, 86‐88]. Indeed, while enteroviruses are largely asymptomatic in non-pregnant patients, they have been shown to induce obstetric complications [64]. The enhanced downregulation of adhesion receptors upon TLR7/TLR8 stimulation in pregnancy-derived monocytes may thus represent a defensive strategy to slow viral entry and potentially protect the fetus at the expense of the mother.
The above concept is further supported by the distinct regulation of CCR5 and CCR2 expression in response to TLR7/TLR8 stimulation of pregnancy-derived monocytes observed herein. The chemokine receptors CCR5 and CCR2 are integral for mediating monocyte trafficking and inflammatory responses [89, 90], and thus the distinct changes in the distribution of pregnancy-derived monocytes expressing these receptors could help to explain the differing susceptibility to viral infection. Specifically, we found that monocytes with a double-positive CCR5+CCR2+ phenotype were diminished in pregnant women compared to non-pregnant, while CCR5−CCR2+ and CCR5−CCR2− subsets were more abundant, suggesting a tendency for enhanced downregulation of these chemokine receptors during viral stimulation. Importantly, CCR5 has been implicated as a co-receptor in viral cell entry by the ssRNA virus HIV-1 [91‐95], with the expression levels of this receptor being directly associated with the rates of monocyte/macrophage infection [96]. Together, these findings provide evidence for distinct modulation of monocyte phenotypes in response to ssRNA viral stimulation during pregnancy that may serve to protect the fetus from vertical transmission. However, the reduced abundance of cells expressing adhesion molecules and chemokine receptors in monocytes from pregnant women exposed to ssRNA viruses may also disrupt the capacity of these immune cells to migrate to sites of infection/inflammation.
Notably, we also found that stimulation of monocytes via TLR7 alone was not associated with differences between pregnant and non-pregnant individuals, suggesting that the differential effects of ssRNA viruses in monocytes from pregnant women are mediated primarily through TLR8. This concept is supported by a previous in vitro investigation of the relationship between placental growth factor-1 (PlGF-1), which increases in the maternal circulation during pregnancy and peaks in the third trimester [97], and CD14+ cellular responses to TLRs stimulation [98]. It was observed that TNF release was enhanced when TLR8 stimulation occurred in the presence of PlGF-1. Moreover, while targeted TLR7 stimulation in the presence of PIGF-1 triggered a mild increase in TNF production, the combined stimulation of TLR7/TLR8 induced the strongest effect [98]. These results suggest that pregnancy-specific physiologic changes can modulate TLR signaling pathways in monocytes, including a greater responsiveness to ssRNA-mediated TLR8 stimulation, which may contribute to an enhanced maternal response to viral infections such as HIV, influenza, and coronaviruses. It is worth mentioning that, despite their shared recognition of ssRNA viral ligands, TLR7 and TLR8 have been reported as modulating distinct signaling pathways in monocytes, resulting in the biased release of cytokines and interferons [99]. Thus, the observed greater dependence on TLR8 signaling for pregnancy-specific responses to ssRNA may have additional implications for subsequent mediator release by maternal monocytes that were not revealed by the analysis performed herein. Moreover, the potential combined action of TLR7 and TLR8 in monocytes has not been adequately investigated and thus the stimulation of both receptors, or crosstalk between their signaling pathways, may have additional effects that are not yet understood [99].
In the current study, we utilized poly(I:C) to induce TLR3 stimulation and thereby model dsRNA viral infection, and found that monocytes expressing CD181 (CD181+CD182+ and CD181+CD182−) were increased, while those without CD181 expression (CD181−CD182+ and CD181−CD182−) were diminished, in pregnant women compared to non-pregnant individuals. More commonly known as CXCR1 and CXCR2, these molecules act as receptors for multiple chemokines including CXCL1 and IL-8 [100‐102]. A prior report indicated that poly(I:C) treatment in pregnant rats resulted in elevated concentrations of multiple mediators in the circulation, including monocyte chemoattractants such as CXCL1, CCL3, and CCL20 [103], supporting the participation of monocyte chemokine signaling pathways as part of the response to TLR3 stimulation. CXCR1 and CXCR2 have overlap in their recognized chemokines and were thought to induce similar functions that centered on neutrophil recruitment [89, 90]. However, reports have suggested that the downstream effects mediated by these receptors may differ; for example, while both CXCR1 and CXCR2 respond to IL-8 (CXCL8), the latter receptor undergoes rapid internalization compared to the former [104]. Thus, the biased modulation of these two chemokine receptors favoring CXCR1-expressing monocytes in response to TLR3 stimulation may indicate a pregnancy-specific program of immune regulation; yet, this concept requires further investigation.
TLR9 is an important component of host defense against dsDNA viruses [44‐46]. Here, we report that stimulation of TLR9 resulted in a modest but consistent increase in intermediate monocytes as well as those expressing chemokine receptors and inflammatory cytokines/chemokines in both pregnant and non-pregnant samples. Our results are consistent with studies demonstrating that TLR9 mRNA is expressed in the murine uterus, cervix, and placenta throughout gestation [105], and that the protein expression of TLR9 in human peripheral leukocytes is unaltered by pregnancy [106]. Given the frequency of encountering dsDNA viruses such as CMV during pregnancy [107‐111], the conservation of TLR9 signaling and its downstream effects may be important for ensuring a sufficient maternal immune response against such common viral threats. Interestingly, alterations in TLR9 signaling resulting from single nucleotide polymorphisms or the activation of this receptor via mtDNA have been linked to obstetrical pathologies such as preeclampsia and spontaneous preterm birth [112‐114]. Moreover, TLR9 has also been proposed to respond to cell-free fetal DNA (cffDNA), small DNA fragments derived from placental cells and released into maternal circulation [115, 116], in the context of obstetrical disease [117‐122], as demonstrated using animal models [123, 124], and in normal term parturition [125, 126]. In light of the reported link between TLR9 signaling and adverse pregnancy outcomes, it is likely that the downstream inflammatory cascade is tightly regulated under steady-state conditions. Regardless, further investigation is required to mechanistically investigate the role of TLR9 responses to pathogen-derived CpGs or cffDNA in pregnancy complications.
Interferons, which represent one of the first lines of soluble defense against pathogens and are critical for an effective anti-viral response, are divided into three types that differ according to their receptor complexes and signal transduction pathways [127]. Here, we determined the release of select Type I, II, and III interferons in response to TLR3 and TLR7/TLR8 stimulation, and noted substantial increases across all mediators in PBMCs from both pregnant and non-pregnant women. The maintenance of interferon signaling is particularly important during pregnancy to protect the fetus against potential congenital infection [128]. Yet, it is worth mentioning that a substantial proportion of human genes can potentially be differentially regulated by interferons; indeed, the family of interferon-stimulated genes (ISGs) continues to grow as new members are identified [129]. Thus, it is possible that, although the released IFN profile appears unchanged during pregnancy, the monocyte signature of ISGs that is modulated by viral signaling may undergo distinct regulation compared to non-pregnant individuals, resulting in a tailored immune response.

Conclusions

Collectively, the data presented herein provide evidence that monocytes from pregnant women display a response to in vitro stimulation with viral ligands that is distinct from the non-pregnant state. Specifically, we demonstrate a differential expression pattern of adhesion molecules and chemokine receptors in pregnancy-derived monocytes exposed to ssRNA and dsRNA viral mimetics that is primarily driven by TLR8 and membrane-bound TLR3, respectively. By contrast, while stimulation of cytosolic TLR3 and TLR9 induced substantial changes in monocyte phenotypes, pregnancy-specific responses were not observed. Notably, the monocyte soluble interferon response to ssRNA or dsRNA viral stimulation remained intact in pregnant women. Taken together, our data provide insight into the specific modifications to the systemic immune response during pregnancy that may help explain the reduced capacity of pregnant women to counteract viral infection, as observed during recent and historic pandemics. The identification of signaling pathways implicated in the pregnancy-specific changes in monocyte phenotypes may allow for a more nuanced assessment of individual risk for infected pregnant women according to the type of virus. Moreover, our findings can serve as a foundation for future research to determine whether monocytes or their affected pathways can serve as targets for preventing or treating viral infection during pregnancy.

Acknowledgements

Figures include art created with BioRender.com.

Declarations

The collection and use of biological specimens for research purposes was approved by the respective Institutional Review Boards of Wayne State University and the Detroit Medical Center (WSU IRB 031318MP2F). Blood sample collection was performed from all women after obtaining written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
insite
INHALT
download
DOWNLOAD
print
DRUCKEN
Anhänge
Literatur
1.
Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33.PubMedCrossRef
2.
3.
Gibson CS, Goldwater PN, MacLennan AH, Haan EA, Priest K, Dekker GA, et al. Fetal exposure to herpesviruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG. 2008;115(4):492–500.PubMedPubMedCentralCrossRef
4.
5.
Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am J Reprod Immunol. 2014;71(5):387–90.PubMedPubMedCentralCrossRef
6.
Charlier C, Beaudoin MC, Couderc T, Lortholary O, Lecuit M. Arboviruses and pregnancy: maternal, fetal, and neonatal effects. Lancet Child Adolesc Health. 2017;1(2):134–46.PubMedCrossRef
7.
Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148(11):1094–102.PubMedCrossRef
8.
9.
Mazumder B, Almond D, Park K, Crimmins EM, Finch CE. Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease. J Dev Orig Health Dis. 2010;1(1):26–34.PubMedPubMedCentralCrossRef
10.
Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol. 2011;205(1):10–8.PubMedCrossRef
11.
Al-Haddad BJS, Oler E, Armistead B, Elsayed NA, Weinberger DR, Bernier R, et al. The fetal origins of mental illness. Am J Obstet Gynecol. 2019;221(6):549–62.PubMedPubMedCentralCrossRef
12.
Chudnovets A, Liu J, Narasimhan H, Liu Y, Burd I. Role of inflammation in virus pathogenesis during pregnancy. J Virol. 2020;95(2):e01381–19.
13.
Cavoretto PI, Fornara C, Baldoli C, Arossa A, Furione M, Candiani M, et al. Prenatal management of congenital human cytomegalovirus infection in seropositive pregnant patients treated with azathioprine. Diagnostics (Basel). 2020;10(8):542.PubMedCrossRef
14.
Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022;226(2):177–86.PubMedCrossRef
15.
Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2023;228(2):161–77.PubMedPubMedCentralCrossRef
16.
Villar J, Soto Conti CP, Gunier RB, Ariff S, Craik R, Cavoretto PI, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023;401(10375):447–57.PubMedPubMedCentralCrossRef
17.
Lilleri D, Tassis B, Pugni L, Ronchi A, Pietrasanta C, Spinillo A, et al. Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study). Clin Infect Dis. 2023;76(3):513–20.PubMedCrossRef
18.
Koonin EV, Dolja VV, Krupovic M, Varsani A, Wolf YI, Yutin N, et al. Global organization and proposed megataxonomy of the virus world. Microbiol Mol Biol Rev. 2020;84(2):e00061–19.
19.
20.
Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1(5):398–401.PubMedCrossRef
21.
Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920–40.PubMedPubMedCentralCrossRef
22.
McCartney SA, Colonna M. Viral sensors: diversity in pathogen recognition. Immunol Rev. 2009;227(1):87–94.PubMedCrossRef
23.
Novella IS, Duarte EA, Elena SF, Moya A, Domingo E, Holland JJ. Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A. 1995;92(13):5841–4.PubMedPubMedCentralCrossRef
24.
Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19(7):409–24.PubMedPubMedCentralCrossRef
25.
Borducchi EN, Cabral C, Stephenson KE, Liu J, Abbink P, Ng’ang’a D, et al. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature. 2016;540(7632):284–7.PubMedPubMedCentralCrossRef
26.
27.
Carty M, Guy C, Bowie AG. Detection of Viral Infections by Innate Immunity. Biochem Pharmacol. 2021;183: 114316.PubMedCrossRef
28.
Westhorpe CL, Zhou J, Webster NL, Kalionis B, Lewin SR, Jaworowski A, et al. Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. J Leukoc Biol. 2009;85(6):1027–35.PubMedPubMedCentralCrossRef
29.
30.
Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and macrophages as viral targets and reservoirs. Int J Mol Sci. 2018;19(9):2821.PubMedPubMedCentralCrossRef
31.
Kennedy JJ, Steain M, Slobedman B, Abendroth A. Infection and functional modulation of human monocytes and macrophages by Varicella-Zoster virus. J Virol. 2019;93(3):e01887–18.
32.
Maheshwari D, Saini K, Singh P, Singla M, Nayak K, Aggarwal C, et al. Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. iScience. 2022;25(6):104384.PubMedPubMedCentralCrossRef
33.
Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349–62.PubMedCrossRef
34.
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 2020;257: 118102.PubMedPubMedCentralCrossRef
35.
Teer E, Joseph DE, Glashoff RH, Faadiel EM. Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset. Virol Sin. 2021;36(4):565–76.PubMedPubMedCentralCrossRef
36.
Janeway CA Jr, Medzhitov R. Introduction: the role of innate immunity in the adaptive immune response. Semin Immunol. 1998;10(5):349–50.PubMedCrossRef
37.
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413(6857):732–8.PubMedCrossRef
38.
Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ. Toll-like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol. 2002;71(3):538–44.PubMedCrossRef
39.
Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303(5663):1526–9.PubMedCrossRef
40.
Girkin JLN, Maltby S, Bartlett NW. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell. Eur Respir Rev. 2022;31(164):210274.
41.
Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008;320(5874):379–81.PubMedPubMedCentralCrossRef
42.
Zhang Z, Ohto U, Shibata T, Taoka M, Yamauchi Y, Sato R, et al. Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands. Cell Rep. 2018;25(12):3371-81 e5.PubMedCrossRef
43.
Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M, et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight. 2021;6(18):e150542.
44.
Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood. 2004;103(4):1433–7.PubMedCrossRef
45.
Basner-Tschakarjan E, Gaffal E, O’Keeffe M, Tormo D, Limmer A, Wagner H, et al. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J Gene Med. 2006;8(11):1300–6.PubMedCrossRef
46.
Samuelsson C, Hausmann J, Lauterbach H, Schmidt M, Akira S, Wagner H, et al. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Invest. 2008;118(5):1776–84.PubMedPubMedCentralCrossRef
47.
Rattay S, Hufbauer M, Hagen C, Putschli B, Coch C, Akgul B, et al. Human beta papillomavirus type 8 E1 and E2 proteins suppress the activation of the RIG-I-Like receptor MDA5. Viruses. 2022;14(7):1361.PubMedPubMedCentralCrossRef
48.
Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441(7089):101–5.PubMedCrossRef
49.
Wong JP, Christopher ME, Viswanathan S, Karpoff N, Dai X, Das D, et al. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine. 2009;27(25–26):3481–3.PubMedPubMedCentralCrossRef
50.
Marques M, Ferreira AR, Ribeiro D. The interplay between human cytomegalovirus and pathogen recognition receptor signaling. Viruses. 2018;10(10):514.PubMedPubMedCentralCrossRef
51.
Chen N, Zhang B, Deng L, Liang B, Ping J. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2. Emerg Microbes Infect. 2022;11(1):1371–89.PubMedPubMedCentralCrossRef
52.
Starbaek SMR, Andersen MR, Brogaard L, Spinelli A, Rapson V, Glud HA, et al. Innate antiviral responses in porcine nasal mucosal explants inoculated with influenza A virus are comparable with responses in respiratory tissues after viral infection. Immunobiology. 2022;227(3): 152192.PubMedPubMedCentralCrossRef
53.
Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80–6.PubMedCrossRef
54.
Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, et al. Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 2012;32(2):300–11.PubMedCrossRef
55.
56.
Farias-Jofre M, Romero R, Galaz J, Xu Y, Tao L, Demery-Poulos C, et al. Pregnancy tailors endotoxin-induced monocyte and neutrophil responses in the maternal circulation. Inflamm Res. 2022;71(5–6):653–68.PubMedPubMedCentralCrossRef
57.
Naccasha N, Gervasi MT, Chaiworapongsa T, Berman S, Yoon BH, Maymon E, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 2001;185(5):1118–23.PubMedCrossRef
58.
Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178(9):5949–56.PubMedCrossRef
59.
Faas MM, de Vos P. Maternal monocytes in pregnancy and preeclampsia in humans and in rats. J Reprod Immunol. 2017;119:91–7.PubMedCrossRef
60.
Zhang J, Shynlova O, Sabra S, Bang A, Briollais L, Lye SJ. Immunophenotyping and activation status of maternal peripheral blood leukocytes during pregnancy and labour, both term and preterm. J Cell Mol Med. 2017;21(10):2386–402.PubMedPubMedCentralCrossRef
61.
Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21(4):446–57.PubMedCrossRef
62.
63.
Ogbuanu IU, Zeko S, Chu SY, Muroua C, Gerber S, De Wee R, et al. Maternal, fetal, and neonatal outcomes associated with measles during pregnancy: Namibia, 2009–2010. Clin Infect Dis. 2014;58(8):1086–92.PubMedCrossRef
64.
Khediri Z, Vauloup-Fellous C, Benachi A, Ayoubi JM, Mandelbrot L, Picone O. Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study. Virol J. 2018;15(1):70.PubMedPubMedCentralCrossRef
65.
Foeller ME, Carvalho Ribeiro do Valle C, Foeller TM, Oladapo OT, Roos E, Thorson AE. Pregnancy and breastfeeding in the context of Ebola: a systematic review. Lancet Infect Dis. 2020;20:e149–58.PubMedCrossRef
66.
67.
68.
Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103(1):E3.PubMedCrossRef
69.
Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178–85.PubMedCrossRef
70.
Raffray L, Giry C, Vandroux D, Kuli B, Randrianjohany A, Pequin AM, et al. Major neutrophilia observed in acute phase of human leptospirosis is not associated with increased expression of granulocyte cell activation markers. PLoS One. 2016;11(11): e0165716.PubMedPubMedCentralCrossRef
71.
Srinivas SK, Ma Y, Sammel MD, Chou D, McGrath C, Parry S, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195(3):797–802.PubMedCrossRef
72.
Tsekoura EA, Konstantinidou A, Papadopoulou S, Athanasiou S, Spanakis N, Kafetzis D, et al. Adenovirus genome in the placenta: association with histological chorioamnionitis and preterm birth. J Med Virol. 2010;82(8):1379–83.PubMedCrossRef
73.
Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147(927):258–67.PubMedCrossRef
74.
Wheelock EF, Sibley WA. Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus. N Engl J Med. 1965;273:194–8.PubMedCrossRef
75.
Iversen MB, Paludan SR. Mechanisms of type III interferon expression. J Interferon Cytokine Res. 2010;30(8):573–8.PubMedCrossRef
76.
Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8–32.PubMedCrossRef
77.
Kasinrerk W, Fiebiger E, Stefanová I, Baumruker T, Knapp W, Stockinger H. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol. 1992;149(3):847–54.PubMedCrossRef
78.
Hahn JN, Kaushik DK, Yong VW. The role of EMMPRIN in T cell biology and immunological diseases. J Leukoc Biol. 2015;98(1):33–48.PubMedCrossRef
79.
Muramatsu T. Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem. 2016;159(5):481–90.PubMedCrossRef
80.
Pata S, Surinkaew S, Takheaw N, Laopajon W, Chuensirikulchai K, Kasinrerk W. Differential CD147 functional epitopes on distinct leukocyte subsets. Front Immunol. 2021;12: 704309.PubMedPubMedCentralCrossRef
81.
Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol. 1992;118(2):445–56.PubMedCrossRef
82.
Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995;128(4):661–71.PubMedCrossRef
83.
McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100(11 Suppl):S97-103.PubMed
84.
85.
Ayala-Nunez NV, Follain G, Delalande F, Hirschler A, Partiot E, Hale GL, et al. Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells. Nat Commun. 2019;10(1):4430.PubMedPubMedCentralCrossRef
86.
Lai J, Romero R, Tarca AL, Iliodromiti S, Rehal A, Banerjee A, et al. SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality. Am J Obstet Gynecol. 2021;225(6):689-93 e1.PubMedPubMedCentralCrossRef
87.
Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(1):68-89 e3.PubMedCrossRef
88.
Gomez-Lopez N, Romero R, Tao L, Gershater M, Leng Y, Zou C, et al. Distinct Cellular immune responses to SARS-CoV-2 in pregnant women. J Immunol. 2022;208(8):1857–72.PubMedCrossRef
89.
Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659–702.PubMedCrossRef
90.
Dyer DP. Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment. Immunology. 2020;160(4):336–44.PubMedPubMedCentralCrossRef
91.
Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272(5270):1955–8.PubMedCrossRef
92.
Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85(7):1135–48.PubMedCrossRef
93.
Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381(6584):661–6.PubMedCrossRef
94.
Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996;85(7):1149–58.PubMedCrossRef
95.
Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381(6584):667–73.PubMedCrossRef
96.
Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol. 1998;72(6):4962–9.PubMedPubMedCentralCrossRef
97.
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–83.PubMedCrossRef
98.
Newell LF, Holtan SG, Yates JE, Pereira L, Tyner JW, Burd I, et al. PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes. Am J Reprod Immunol. 2017;78(4):e12709.
99.
de Marcken M, Dhaliwal K, Danielsen AC, Gautron AS, Dominguez-Villar M. TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection. Sci Signal. 2019;12(605):eaaw1347.
100.
Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem. 1992;267(23):16283–7.PubMedCrossRef
101.
Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 1996;271(34):20545–50.PubMedCrossRef
102.
Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem. 1998;255(1):67–73.PubMedCrossRef
103.
Brown AM, Conn I, Boerrigter D, Shannon Weickert C, Purves-Tyson TD. Maternal immune activation with high molecular weight poly(I:C) in Wistar rats leads to elevated immune cell chemoattractants. J Neuroimmunol. 2022;364: 577813.PubMedCrossRef
104.
Richardson RM, Marjoram RJ, Barak LS, Snyderman R. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol. 2003;170(6):2904–11.PubMedCrossRef
105.
Gonzalez JM, Xu H, Ofori E, Elovitz MA. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol. 2007;197(3):296 e1-6.PubMedCrossRef
106.
Madanchi H, Danaei N, Safarieh E, Mousavi Maleki MS, Rostamian M, Taheri R, et al. Expression of cathelicidin, ERK, MyD88, and TLR-9 in the blood of women in the pre-pregnancy, pregnancy, and their infant cord blood. Hum Immunol. 2022;83(12):826–31.PubMedCrossRef
107.
Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15(4):680–715.PubMedPubMedCentralCrossRef
108.
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–76.PubMedCrossRef
109.
Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis. 2010;50(11):1439–47.PubMedCrossRef
110.
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13.PubMedCrossRef
111.
Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010;20(5):311–26.PubMedCrossRef
112.
Williamson RD, McCarthy FP, Kenny LC, McCarthy CM. Activation of a TLR9 mediated innate immune response in preeclampsia. Sci Rep. 2019;9(1):5920.PubMedPubMedCentralCrossRef
113.
Wujcicka WI, Kacerovsky M, Krekora M, Kaczmarek P, Grzesiak M. Single nucleotide polymorphisms from CSF2, FLT1, TFPI and TLR9 genes are associated with prelabor rupture of membranes. Genes (Basel). 2021;12(11):1725.PubMedCrossRef
114.
Wujcicka WI, Kacerovsky M, Krygier A, Krekora M, Kaczmarek P, Grzesiak M. Association of Single Nucleotide Polymorphisms from Angiogenesis-Related Genes, ANGPT2, TLR2 and TLR9, with Spontaneous Preterm Labor. Curr Issues Mol Biol. 2022;44(7):2939–55.PubMedPubMedCentralCrossRef
115.
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.PubMedCrossRef
116.
Taglauer ES, Wilkins-Haug L, Bianchi DW. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35(Suppl):S64–8.PubMedCrossRef
117.
Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 1998;352(9144):1904–5.PubMedCrossRef
118.
Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol. 2004;190(3):707–13.PubMedCrossRef
119.
Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2005;193(2):421–5.PubMedCrossRef
120.
Scharfe-Nugent A, Corr SC, Carpenter SB, Keogh L, Doyle B, Martin C, et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol. 2012;188(11):5706–12.PubMedCrossRef
121.
Crawford CL. Comment on “TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia.” J Immunol. 2013;190(12):5909.PubMedCrossRef
122.
Contro E, Bernabini D, Farina A. Cell-Free Fetal DNA for the prediction of pre-eclampsia at the first and second trimesters: a systematic review and meta-analysis. Mol Diagn Ther. 2017;21(2):125–35.PubMedCrossRef
123.
Thaxton JE, Romero R, Sharma S. TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol. 2009;183(2):1144–54.PubMedCrossRef
124.
Sun Y, Qin X, Shan B, Wang W, Zhu Q, Sharma S, et al. Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls. Fertil Steril. 2013;99(6):1759–67.PubMedPubMedCentralCrossRef
125.
Phillippe M. Cell-free fetal DNA, telomeres, and the spontaneous onset of parturition. Reprod Sci. 2015;22(10):1186–201.PubMedCrossRef
126.
Herrera CA, Stoerker J, Carlquist J, Stoddard GJ, Jackson M, Esplin S, et al. Cell-free DNA, inflammation, and the initiation of spontaneous term labor. Am J Obstet Gynecol. 2017;217(5):583 e1-e8.PubMedCrossRef
127.
Negishi H, Taniguchi T, Yanai H. The Interferon (IFN) class of cytokines and the IFN Regulatory Factor (IRF) transcription factor family. Cold Spring Harb Perspect Biol. 2018;10(11):a028423.
128.
129.
Schoggins JW. Interferon-stimulated genes: what do they all do? Annu Rev Virol. 2019;6(1):567–84.PubMedCrossRef
Metadaten
Titel
Differential immunophenotype of circulating monocytes from pregnant women in response to viral ligands
verfasst von
Marcelo Farias-Jofre
Roberto Romero
Yi Xu
Dustyn Levenson
Li Tao
Tomi Kanninen
Jose Galaz
Marcia Arenas-Hernandez
Zhenjie Liu
Derek Miller
Gaurav Bhatti
Megan Seyerle
Adi L. Tarca
Nardhy Gomez-Lopez
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2023
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-05562-0

Weitere Artikel der Ausgabe 1/2023

BMC Pregnancy and Childbirth 1/2023 Zur Ausgabe

Correction

Correction: Ultrasound for diagnosis of postpartum retained products of conception—how accurate we are?

Research

Rates of and factors associated with exclusive and any breastfeeding at six months in Canada: an analysis of population-based cross-sectional data

Research

Analysis of risk factors and construction of nomograph model for critical condition of patients with hypertension during pregnancy

Research

Measurement of maternal morbidity during postpartum with the WHO-WOICE tools in Morocco

Research

Community-based perinatal mental health peer support: a realist review

Research

Cost-effectiveness and budget impact of adding tranexamic acid for management of post-partum hemorrhage in the Indian public health system

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise